Interaction of Vitamin D Receptor with HLA DRB1 0301 in Type 1 Diabetes Patients from North India

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2009 Dec 4

PMID 19956544

Citations 21

Authors

Neetu Israni

Ravinder Goswami

Avinash Kumar

Rajni Rani

Affiliations

Soon will be listed here.

Abstract

Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where interaction and integration of immune response genes along with environmental factors play a role in autoimmune destruction of the insulin producing Pancreatic Beta cells.

Methodology/principal Findings: We have studied four single nucleotide polymorphisms (FokI site in Exon 2, BsmI and ApaI sites in Intron 8 and TaqI site in exon 9) in the vitamin D receptor (VDR) gene using PCR-RFLP and HLA-DRB1 alleles using PCR and hybridization with sequence specific oligonucleotide probes and studied their interaction using LD based statistics for non-linked loci followed by sequence analysis of the vitamin D response element (VDRE) present in the promoter region of HLA-DRB1 0301. Haplotypes, constructed using SHEsis program for four single nucleotide polymorphisms in the VDR gene, were studied for their interaction with HLA-DRB1 alleles in 233 T1D patients and 191 healthy controls from North India. A significant increase of haplotypes FBAt and fBAT (p<0.02, OR = 1.44 and p<0.002, OR = 3.23 respectively) was observed in the patients. Both the haplotypes FBAt and fBAT were significantly increased in male patients with age at onset less than 18 years; however, fBAT was significantly increased in female patients irrespective of their age at onset. LD based statistics showed significant interaction between the high producer F and T alleles with HLA-DRB1 0301. F and T alleles of VDR have been shown to contribute to VDR mRNA independently. The promoter sequence analysis of HLA-DRB1 0301 showed presence of VDRE involved in higher expression of HLA-DRB1 030, which was confirmed by flow cytometry and real time PCR analysis.

Conclusions/significance: These data suggest that the interaction between VDR and HLA alleles is mediated by VDRE present in the promoter region of HLA-DRB1 0301 allele, which may be detrimental for the manifestation of T1D in the absence of 1,25-(OH)(2)D(3) in early childhood due to poor expression of DRB1 0301 in the thymus resulting in autoimmunity.

Citing Articles

Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management.

Mourelatou N, Kounatidis D, Jude E, Rebelos E Nutrients. 2024; 16(23).

PMID: 39683465 PMC: 11643312. DOI: 10.3390/nu16234072.

Association of Vitamin D Deficiency and Vitamin D Receptor Gene Polymorphisms with Type 1 Diabetes Risk: A South Indian Familial Study.

Thirunavukkarasu R, Chitra A, Asirvatham A, Jayalakshmi M J Clin Res Pediatr Endocrinol. 2023; 16(1):21-30.

PMID: 37559366 PMC: 10938518. DOI: 10.4274/jcrpe.galenos.2023.2022-12-7.

Tissue-Specific Variations in Transcription Factors Elucidate Complex Immune System Regulation.

Lu H, Tang Y, Gottlieb A Genes (Basel). 2022; 13(5).

PMID: 35627314 PMC: 9140347. DOI: 10.3390/genes13050929.

Genetic Polymorphisms of Vitamin D Receptor Gene are Associated with Cervical Cancer Risk in Northeastern Thailand.

Phuthong S, Settheetham-Ishida W, Natphopsuk S, Ishida T Asian Pac J Cancer Prev. 2020; 21(10):2935-2939.

PMID: 33112551 PMC: 7798167. DOI: 10.31557/APJCP.2020.21.10.2935.

Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: a meta-regression and updated meta-analysis.

Zhai N, Bidares R, Makoui M, Aslani S, Mohammadi P, Razi B BMC Endocr Disord. 2020; 20(1):121.

PMID: 32771009 PMC: 7414991. DOI: 10.1186/s12902-020-00575-8.

References

Morrison N, Yeoman R, Kelly P, Eisman J . Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A. 1992; 89(15):6665-9. PMC: 49563. DOI: 10.1073/pnas.89.15.6665. View

Mathieu C, Laureys J, SOBIS H, Vandeputte M, Waer M, Bouillon R . 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes. 1992; 41(11):1491-5. DOI: 10.2337/diab.41.11.1491. View

Lemire J . Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992; 49(1):26-31. DOI: 10.1002/jcb.240490106. View

Motohashi Y, Yamada S, Yanagawa T, Maruyama T, Suzuki R, Niino M . Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab. 2003; 88(7):3137-40. DOI: 10.1210/jc.2002-021881. View

Durrin L, Haile R, Ingles S, Coetzee G . Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta. 1999; 1453(3):311-20. DOI: 10.1016/s0925-4439(99)00007-1. View

Shi Y, He L . SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15(2):97-8. DOI: 10.1038/sj.cr.7290272. View

Zmuda J, Cauley J, Ferrell R . Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2001; 22(2):203-17. DOI: 10.1093/oxfordjournals.epirev.a018033. View

Alroy I, Towers T, Freedman L . Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995; 15(10):5789-99. PMC: 230831. DOI: 10.1128/MCB.15.10.5789. View

Chang T, Lei H, Yeh J, Chiu K, Lee K, Chen M . Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol (Oxf). 2000; 52(5):575-80. DOI: 10.1046/j.1365-2265.2000.00985.x. View

10.

Sandelin A, Alkema W, Engstrom P, Wasserman W, Lenhard B . JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2003; 32(Database issue):D91-4. PMC: 308747. DOI: 10.1093/nar/gkh012. View

11.

Faraco J, Morrison N, Baker A, Shine J, Frossard P . ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res. 1989; 17(5):2150. PMC: 317576. DOI: 10.1093/nar/17.5.2150. View

12.

Zella J, McCary L, Deluca H . Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003; 417(1):77-80. DOI: 10.1016/s0003-9861(03)00338-2. View

13.

Louis P, Eliaou J, Pinet V, Vincent R, Clot J . Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. Immunogenetics. 1993; 38(1):21-6. DOI: 10.1007/BF00216386. View

14.

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

15.

McDermott M, Ramachandran A, Ogunkolade B, Aganna E, Curtis D, Boucher B . Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia. 1997; 40(8):971-5. DOI: 10.1007/s001250050776. View

16.

Kumar R, Goswami R, Agarwal S, Israni N, Singh S, Rani R . Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens. 2007; 69(6):557-67. DOI: 10.1111/j.1399-0039.2007.00817.x. View

17.

Hustmyer F, DeLuca H, Peacock M . ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum Mol Genet. 1993; 2(4):487. DOI: 10.1093/hmg/2.4.487. View

18.

Yu X, Bellido T, Manolagas S . Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1995; 92(24):10990-4. PMC: 40556. DOI: 10.1073/pnas.92.24.10990. View

19.

Turpeinen H, Hermann R, Vaara S, Laine A, Simell O, Knip M . Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur J Endocrinol. 2003; 149(6):591-6. DOI: 10.1530/eje.0.1490591. View

20.

Bhalla A, Amento E, Serog B, Glimcher L . 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984; 133(4):1748-54. View